European S3-Guidelines on the systemic treatment of psoriasis vulgaris. The publication of these guidelines was supported by educational grants from Abbott International, Illinois, US, Essex Pharma GmbH, Munich, Germany and Wyeth Pharma GmbH, Münster, Germany